BGU Initiates Project to Eliminate Intestinal Worms in EthiopiaBGU Professor Zvi Bentwich, who heads The Center for Emerging Diseases, Tropical Diseases and AIDS in Israel (CEMTA), is beginning an intensive program in Ethiopia to eradicate intestinal worms which affect as much as 50 percent of the population in Africa.
Alcohol May Lower Blood SugarReuters--In people with type 2 diabetes, a daily glass of wine with dinner lowers fasting blood sugar levels, BGU researchers found.
New Device Aids Operating Room SterilityUPI--A new hand gesture recognition system created at Ben-Gurion University of the Negev and tested at a Washington, D.C. hospital enables doctors to use hand motions instead of touching a screen, keyboard or mouse to monitor images, minimizing the risk of infection.
Israel’s PhagoLum to Make Sepsis HistoryIsrael 21c--Early diagnosis and treatment choice for sepsis is a daily challenge in intensive care units. A new diagnostic kit is expected to be in hospital labs by the end of 2010, based on research developed by BGU scientists.
Researcher Identifies Early Cardiac Risk in Sleep DisorderSouth Florida Sun-Sentinel--A Ben-Gurion University-led research team discovered that Obstructive Sleep Apnea (OSA) can manifest similar cardiovascular complications in young children as it does in older children and adults.
Going Viral: Israeli Doctor Fights Disease around the WorldJ Weekly--Dr. Michael Alkan, BGU professor emeritus of medicine, might turn up in Botswana to teach local doctors how to combat infectious diseases. Or he might spend a month in Ecuador setting up a hospital.
Can Seaweed Mend a Broken Heart?Scientific American--New research indicates that an alginate-based biomaterial injected into heart attack victims may stave off further damage.
BGU Study Fuels Low-Fat vs. Low-Carb DebateThe Wall Street Journal--Overweight people on low-carbohydrate and Mediterranean diets lost more weight and got greater cardiovascular benefits than people on a conventional low-fat diet.
Shining a Light on InfectionA new type of fiber optic biosensor-enabled blood test that resembles a pen rapidly determines what type of infection a patient has and whether he needs antibiotics. The biopen, called PhagoLum, was developed by Drs. Moni Magrisso and Robert Marks of BGU's National Institute for Biotechnology in the Negev and could be on the market by 2009.
back to previous page